Venous Thromboembolism

Related by string. venous thromboembolism * venous : intra venous / thromboembolisms : venous thromboembolism VTE prophylaxis * venous thromboembolism prophylaxis . venous thromboembolism VTE . Venous thromboembolism VTE . Venous Thromboembolism VTE . recurrent venous thromboembolism . preventing venous thromboembolism . venous thromboembolism blood clot *

Related by context. All words. (Click for frequent words.) 80 Ischemic Stroke 80 Patients Undergoing 80 Cardiovascular Events 80 Carotid Stenting 79 Statin Therapy 79 Postmenopausal Women 79 Cardiovascular Outcomes 79 Fracture Risk 79 Breast Cancer Recurrence 78 Appears Safe 78 Rheumatoid Arthritis Patients 78 Invasive Breast Cancer 78 Localized Prostate Cancer 78 Clinical Outcome 78 Adjuvant Chemotherapy 78 Improves Survival 78 Hip Fracture 78 Radical Prostatectomy 77 Combination Treatment 77 Metastatic Prostate Cancer 77 Neoadjuvant Chemotherapy 77 Knee Osteoarthritis 76 Systematic Review 76 Cognitive Impairment 76 Multiple Myeloma Patients 76 Hormone Therapy 76 Renal Cell Carcinoma 76 Bone Metastases 76 Obese Patients 76 Treating Chronic 76 Acute Coronary Syndromes 76 Patients Receiving 76 Myocardial Ischemia 76 Thromboembolism 76 Breast Cancer Treatment 76 Hypertensive Patients 76 Randomized Trials 76 Heart Failure Patients 76 Advanced Melanoma 76 Overactive Bladder 76 Meta Analysis 76 Bone Fractures 76 Improves Outcomes 76 Randomized Controlled Trials 76 Liver Failure 75 Shows Efficacy 75 Reduces Mortality 75 Survival Benefit 75 Fungal Infections 75 Elderly Patients 75 Prostate Cancer Patients 75 Pooled Analysis 75 Estrogen Therapy 75 Surgical Treatment 75 Gastric Cancer 75 Increased Mortality 75 Unfractionated Heparin 75 Lowers Risk 75 Periodontal Disease 75 Resistant Hypertension 75 Clostridium difficile Infection 75 See CLINICAL PHARMACOLOGY 75 Reduced Risk 75 Blood Clots 75 Osteoporosis Treatment 75 Prolongs Survival 75 Platelet Inhibition 75 Treatment Reduces 75 Adjuvant Therapy 75 Diabetic Patients 74 Patients Treated 74 Randomized Controlled Trial 74 Pediatric Patients 74 Cancer Recurrence 74 Long Term Outcomes 74 Radiofrequency Ablation 74 Osteoporosis Drug 74 Advanced Ovarian Cancer 74 Aggressive Prostate Cancer 74 Septic Shock 74 Sleep Disturbances 74 HER2 Positive 74 Antidepressant Use 74 Improve Survival 74 Endometrial Cancer 74 Kidney Function 74 Mortality Risk 74 Statistically Significant 74 Increases Risk 74 HER2 Positive Breast Cancer 74 Skin Lesions 74 Prognostic Value 74 Colorectal Adenomas 74 Prostate Surgery 74 Preterm Delivery 74 Drug Prevents 74 Inhaled Steroids 74 Hemodialysis Patients 74 Controlled Study 74 Drug Coated Stents 74 Stent Implantation 74 Advanced Prostate Cancer 74 Breast Cancer Patients 74 Lung Injury 74 Demonstrates Efficacy 74 Newly Diagnosed Multiple Myeloma 74 Hepatocellular Carcinoma 74 Total Knee Arthroplasty 74 Kidney Failure 74 Osteoporosis Drugs 74 Hormone Receptor Positive 74 Improved Survival 74 Cardiac Resynchronization 74 Artery Disease 74 Patients Treated With 74 Postmenopausal Osteoporosis 74 Predict Risk 74 Enlarged Prostate 74 Carotid Endarterectomy 74 Depressive Symptoms 74 Lung Cancers 74 Long Term Efficacy 74 Hormone Refractory Prostate Cancer 73 Severe Sepsis 73 Subgroup Analysis 73 Relapsing Multiple Sclerosis 73 Long Term Survival 73 Cholesterol Lowering Drug 73 Colorectal Cancers 73 Oral Fingolimod 73 Osteoarthritis Patients 73 Recurrent Stroke 73 Pregnancy Linked 73 Effectively Treats 73 Investigational Agent 73 Combo Therapy 73 Myeloma Patients 73 Psychiatric Disorders 73 Stent Placement 73 Kidney Transplantation 73 Study Showed 73 Statin Drugs 73 Patients Suffering 73 Premature Infants 73 Prostate Cancer Treatment 73 Drug Combo 73 Colorectal Cancer Patients 73 Prophylactic Treatment 73 Patient Outcomes 73 Functional Outcomes 73 Minimally Invasive Treatment 73 Critically Ill Patients 73 Cardiovascular Disease Risk 73 Gum Disease 73 Hip Fractures 73 Autoimmune Disease 73 Antitumor Activity 73 Prognostic Factors 73 Uterine Fibroid Embolization 73 Epilepsy Drug 73 Acute Ischemic Stroke 73 Study Evaluating 73 Migraine Headaches 73 Lung Cancer Patients 73 Hypercholesterolemia 73 Acute Myocardial Infarction 73 Pulmonary Arterial Hypertension 73 Epilepsy Drugs 73 Drug Shows Promise 73 Randomized Clinical Trial 73 Treatment Naive Patients 73 Prospective Randomized 73 Cognitive Function 73 Serious Infections 73 Controlled Trial 73 Hematological Cancers 73 Antiplatelet Therapy 73 Reduce Mortality 73 Venous Thrombosis 73 Organ Rejection 73 Tiotropium 73 Infarction 73 Clinical Trial Results 73 Renal Anemia 73 Levels Linked 73 Recurrent Breast Cancer 73 Preterm Infants 73 Menopausal Symptoms 73 Chronic Heart Failure 73 Glycemic Control 73 Antibiotic Use 73 Proven Effective 73 Potentially Fatal 72 Therapy Improves 72 Cholesterol Levels 72 Thrombotic 72 Adverse Effects 72 Proves Effective 72 Aggressive Reduction 72 Antibiotic Treatment 72 Statin Use 72 Shows Promising 72 Fondaparinux 72 Chronic Hepatitis C 72 Kidney Transplant Patients 72 Myelodysplastic Syndromes 72 Gene Linked 72 Chronic Sinusitis 72 Laryngeal Cancer 72 Complication Rates 72 Multicenter Trial 72 Autologous Stem Cell Transplantation 72 Partial Onset Seizures 72 Orthostatic Hypotension 72 Versus Placebo 72 Boosts Survival 72 Intracerebral Hemorrhage 72 Diagnosis Treatment 72 Shows Promise Against 72 Randomized Double Blind 72 Randomized Study 72 Left Ventricular 72 Medication Errors 72 Acute Pancreatitis 72 Phase 2b Clinical Trial 72 Differential Diagnosis 72 Suicidality 72 Investigational Compound 72 Enoxaparin 72 Allergic Rhinitis 72 Inflammatory Markers 72 Diabetic Nephropathy 72 Acute Pain 72 Clinical Trial Data 72 Clinical Efficacy 72 Urinary Incontinence 72 Slow Progression 72 Vitamin D Deficiency 72 Severe Acne 72 Hospital Acquired Pneumonia 72 Acute Heart Failure 72 Renal Function 72 Uterine Fibroids 72 Meets Primary Endpoint 72 Pneumococcal Vaccine 72 Often Misdiagnosed 72 Treatment Regimen 72 Aortic Valve Replacement 72 Single Dose 72 Unstable Angina 72 Medication Adherence 72 Genes Linked 72 Guidelines Issued 72 Stem Cell Treatment 72 Gastric Bypass Surgery 72 Obesity Linked 72 Treating Depression 72 Risk Stratification 72 Thromboembolic 72 Invasive Fungal Infections 72 Adjuvant Treatment 72 Demonstrated Significant 72 Renal Impairment 72 Tumor Growth 72 Bone Mineral Density 72 Phase 2b Study 72 Asthma Symptoms 72 ST Segment Elevation 72 Disease Progression 72 Stent Thrombosis 72 Renal Cancer 72 Percutaneous Coronary Intervention 72 CT Angiography 72 Lupus Drug 72 Prolongs Life 72 Increased Risk 72 Previously Treated 72 Adverse Event 72 Prostatectomy 72 Bare Metal Stents 72 Improve Outcomes 72 Respiratory Infections 72 Inhaled Corticosteroids 72 Significantly Reduced 72 Radiation Dose 72 Rotavirus Vaccine 72 Blood Pressure Reduction 72 Clinical Outcomes 72 Diagnostic Criteria 72 Breast Cancers 72 Ventricular Arrhythmias 71 Surgical Procedures 71 Liver Damage 71 ST Elevation Myocardial 71 Fixed Dose 71 Obese Teens 71 Deep Venous Thrombosis 71 Non Invasive Treatment 71 Phase IIb Trial 71 Therapy Shows Promise 71 Severe Asthma 71 Radiation Exposure 71 Genetic Markers 71 Liver Metastases 71 MRSA Infections 71 Gene Variation 71 Preterm Labor 71 Significantly Reduces 71 Zoledronic Acid 71 Treated Patients 71 Chronic Hepatitis B 71 Survival Rates 71 Node Positive 71 Dual Antiplatelet Therapy 71 Coronary Artery Bypass Graft 71 Cognitive Decline 71 Dose Escalation 71 Smoking Linked 71 Placebo Controlled Trial 71 Antipsychotic Medications 71 Skeletal Muscle 71 Demonstrates Positive 71 Monotherapy 71 Investigational Drug 71 Chronic Renal Failure 71 Anti Clotting Drug 71 Suicidal Ideation 71 Chemotherapeutic Agents 71 Double Blind Placebo 71 Clinical Evaluation 71 Panic Disorder 71 Sustained Efficacy 71 Newly Diagnosed Breast Cancer 71 Stomach Cancer 71 Renal Artery 71 Blocked Arteries 71 Clinical Trial Evaluating 71 Kidney Transplants 71 CABG Surgery 71 Solid Tumors 71 Investigational Treatment 71 Migraine Headache 71 Transplant Patients 71 Beta Blocker 71 Premenopausal Women 71 Well Tolerated 71 Demonstrates Sustained 71 ORLive Presents 71 Prostate Cancer Recurrence 71 Hepatitis C Genotype 71 Phase III Clinical Trial 71 Stem Cell Transplants 71 HCV Protease Inhibitor 71 Novel Treatments 71 Hematopoietic Stem Cell Transplantation 71 Hormone Replacement 71 Aneurysm Repair 71 Protein Linked 71 Adenoma 71 See WARNINGS 71 Rectal Cancer 71 ER Visits 71 Androgen Deprivation Therapy 71 Gene Variant 71 Symptom Relief 71 Cardiogenic Shock 71 Bone Fracture 71 Treating Heart Failure 71 Iron Deficiency 71 Total Hip Replacement 71 Successfully Treated 71 Cardiac Function 71 Asthma Attacks 71 Blood Pressure Drugs 71 Breast Tumors 71 Brain Tumors 71 Renal Transplantation 71 Genes Predict 71 Pulmonary Artery 71 Newly Diagnosed 71 Lung Function 71 Coronary Disease 71 Acne Drug 71 FDA Approves Drug 71 Lowering Blood Pressure 71 Excessive Sweating 71 Robotic Assisted 71 Anticancer Drugs 71 Therapy Reduces 71 Postmenopausal 71 Lung Cancer Survival 71 Gout Drug 71 Hepatitis C Virus 71 Castration Resistant Prostate Cancer 71 Menopausal Women 71 Test Detects 71 Gene Mutations 71 Nicotine Vaccine 71 Phase III Trial 71 Migraine Pain 71 Fewer Side Effects 71 Hospitalized Patients 71 Arterial Disease 71 Coronary Revascularization 71 Prevent Stroke 71 Lung Cancer Trial 71 Esophageal Cancer 71 Placebo Controlled Study 71 Breast Carcinoma 71 Less Invasive 71 Aortic Stenosis 71 Ovary Removal 70 Anthracycline 70 Significant Reduction 70 Blood Pressure Drug 70 Brain Atrophy 70 Relapsed Multiple Myeloma 70 Heartburn Drugs 70 Chronic Constipation 70 Who Underwent 70 Vertebral Fractures 70 Experimental Vaccine 70 Ovarian Cancer Patients 70 Blood Thinner 70 Nesiritide 70 Bivalirudin 70 Antiplatelet 70 Chemotherapy Regimen 70 Cardiovascular Risk Factors 70 Bladder Cancer 70 Metastatic Colorectal Cancer 70 Malignant Melanoma 70 Left Ventricular Hypertrophy 70 Anti Tumor Activity 70 Comorbidities 70 Randomised Trial 70 Myocardial Infarction 70 Patient Enrollment 70 Antidepressants Linked 70 Randomized Double blind 70 Intracranial Aneurysms 70 Pregnancy Outcomes 70 Is Well Tolerated 70 Subtypes 70 Cost Effectiveness 70 Bacterial Infection 70 Slows Progression 70 Cholesterol Levels SPARCL 70 Sleep Disturbance 70 Secondhand Smoke Exposure 70 Secondary Hyperparathyroidism 70 Gastrointestinal Disorders 70 Early Diagnosis 70 Viral Infections 70 ACE Inhibitors 70 Prostate Biopsy 70 Commonly Used 70 Gene Mutation 70 Cervical Dysplasia 70 Blood Clot Risk 70 Prolonged Survival 70 Treatment Shows Promise 70 Randomized Clinical Trials 70 Antipsychotic Drug 70 Pre Cancerous 70 Reduces Risk 70 Phase IIb Clinical Trial 70 Liver Injury 70 Relapsing Remitting Multiple Sclerosis 70 Rare Genetic 70 Alcohol Consumption 70 Bloodstream Infections 70 Chronic Insomnia 70 Respiratory Distress 70 Effective Treatments 70 Opioid Use 70 Elevated Levels 70 Kidney Transplant Recipients 70 Progressive Multifocal Leukoencephalopathy 70 Preterm Birth 70 Pressure Ulcers 70 Hospitalization Rates 70 Randomized Comparison 70 Valvular Heart Disease 70 Metabolic Disorder 70 Renal Tumors 70 Dementia Risk 70 Cancer Treatments 70 Advanced Colorectal Cancer 70 Moderate Drinking 70 Randomised Controlled Trial 70 Benign Prostatic Hyperplasia 70 Insulin Glargine 70 Breast Cancer Risk 70 Asthma Treatment 70 Stress Induced 70 Atopic Dermatitis 70 Adjunctive Therapy 70 Immune Responses 70 Strongly Linked 70 Viral Suppression 70 Fibromyalgia Pain 70 Heart Attacks 70 Arthritis Drug 70 Hepatitis C Treatment 70 Endothelial Function 70 Treatment Resistant 70 Insulin Therapy 70 Postherpetic Neuralgia 70 Post Operative 70 Urinary Tract Infections 70 Aortic Valve 70 Ischemic 70 Genes Identified 70 Suicidal Behavior 70 entitled Formulary Advantages 70 Chemotherapy Improves 70 Confirms Efficacy 70 Tumor Response 70 Lymph Nodes 70 Combination Therapy 70 Anemia Drug 70 Clinical Practice Guideline 70 Plaque Psoriasis 70 Sleep Duration 70 Insulin Resistance 70 Cholesterol Drug 70 Abciximab 70 FDA Approvals 70 Glucose Levels 70 Gender Differences 70 Genetic Variation 70 Insulin Sensitivity 70 Brain Scans 70 Male Infertility 69 Prospective Cohort Study 69 Chronic Cough 69 Chemoradiation 69 Lung Cancer Risk 69 Chronic Inflammation 69 Cholesterol Drugs 69 Endovascular Treatment 69 Skin Cancers 69 Thrombus 69 Intracerebral 69 Shingles Vaccine 69 Pharmacokinetic Study 69 Regimens 69 Chronic Bronchitis 69 Soft Tissue Sarcoma 69 Ranolazine 69 Inhaled Nitric Oxide 69 Breast Density 69 Stable Coronary Artery 69 Genetic Tests 69 Prevent Breast Cancer 69 Inflammatory Arthritis 69 Mitral Regurgitation 69 Dialysis Patients 69 Node Negative 69 Neuroendocrine Tumors 69 Diagnostic Tests 69 Bacterial Infections 69 Allergic Reactions 69 Study Demonstrates 69 Breast Reconstruction 69 Anticoagulation 69 Glatiramer Acetate 69 Prostate Cancers 69 Hormonal Therapy 69 Study Casts Doubt 69 Treat Heart Failure 69 Antiviral Drugs 69 Non Responders 69 Prospective Multicenter 69 Breast Tumor 69 First Patient Enrolled 69 Contrast Agents 69 Brain Metastases 69 Postmarketing 69 Randomized Controlled 69 Patency 69 Complicated Skin 69 Cardiotoxicity 69 Immune Mediated 69 Significantly Improved 69 Osteoarthritis Pain 69 Spinal Fractures 69 Colorectal Cancer Risk 69 Prognostic Significance 69 Demonstrates Significant 69 Uterine Cancer 69 Demonstrate Significant 69 Data Suggest 69 Bypass Surgery 69 Fecal Incontinence 69 Drug Resistant 69 Postoperative Pain 69 #-# Full Text 69 Protein Involved 69 Gestational Diabetes 69 Coronary Angiography 69 Antipsychotic Drugs 69 Stent Restenosis 69 Eye Infections 69 Premature Death 69 Poorly Controlled 69 Beta Blockers 69 Sustained Reduction 69 Physician Insights 69 Blood Cancers 69 Liver Tumors 69 Hepatotoxicity 69 Antidepressant Treatment 69 NDA Submission 69 Testosterone Patch 69 FDA Panel Recommends 69 Genetic Variant 69 Anal Cancer 69 Prostate Cancer Screening 69 Microalbuminuria 69 Colorectal Cancer Screening 69 Catheter Associated 69 Therapeutic Potential 69 Doctors Warn 69 Coronary Artery Calcium 69 Sexual Function 69 Chronic Liver Disease 69 Unresectable 69 Corneal Transplant 69 Genes Involved 69 Infected Patients 69 Squamous Cell Carcinoma 69 Initiates Clinical Trial 69 Aortic Aneurysm 69 Cardiovascular Risk 69 Spinal Fusion 69 Aromatase Inhibitors 69 Predict Breast Cancer 69 Drug Resistant TB 69 Iron Overload 69 Colorectal Screening 69 Genes Associated 69 Metastatic Renal Cell Carcinoma 69 COPD Exacerbations 69 Metastases 69 Screening Mammography 69 Antifungals 69 Low Dose 69 Preclinical Data 69 Rapidly Increasing 69 Nonalcoholic Fatty Liver Disease 69 Balloon Angioplasty 69 Generalized Anxiety Disorder 69 Topical Treatment 69 Sleep Disordered Breathing 69 Rhinosinusitis 69 Advanced Renal Cell 69 Breathing Problems 69 Molecular Basis 69 Randomized Phase II 69 Chronic Lyme Disease 69 Beneficial Effects 69 Renal Insufficiency 69 Sinus Infections 69 Inflammatory Diseases 69 Epileptic Seizures 69 Smallpox Vaccine 69 Hemoglobin Levels 69 Clot Risk 69 Colon Polyps 69 Coronary Arteries 69 Diabetic Neuropathy 69 Effective Than 69 Shown Effective 69 Anticoagulants 68 Tolerability 68 Improve Diagnosis 68 Cancer Diagnosis 68 Prophylaxis 68 Novel Mechanism 68 Reperfusion Injury 68 Thyroid Hormone 68 Multicenter Study 68 Cognitive Problems 68 Restenosis 68 Helps Predict 68 Cognitive Deficits 68 Anticancer Activity 68 Physical Function 68 Ovarian Cancer Risk 68 Virus Linked 68 Mouse Model 68 Migraine Drug 68 Brain Lesions 68 Cervical Spine 68 Ear Infections 68 Muscle Function 68 Adverse Events 68 Vaccine Protects Against 68 JAK Inhibitor 68 Liver Toxicity 68 Drug Candidate 68 Radiation Induced 68 Study Proves 68 Bone Marrow Transplants 68 Previously Untreated 68 Coronary Artery 68 Diabetic Foot Ulcer 68 Lung Cancer Drug 68 Prostate Cancer Risk 68 Cardiovascular Mortality 68 Chronic Wounds 68 Stable Angina 68 Drug Eluting Stents 68 Illicit Drug Use 68 Prostate Cancer Surgery 68 Ovarian Cancers 68 Nymox NX 68 Study Shows Benefits 68 Brain Function 68 FDA Okays 68 Stress Fractures 68 Oral Contraceptive 68 Prostate Tumors 68 Malignancies 68 Phase III Pivotal Trial 68 Pain Relievers 68 Smallpox Vaccination 68 Anticoagulant 68 Phase III Trials 68 Prostate Cancer Vaccine 68 Inflammatory Response 68 Cancer Incidence Mortality 68 Emerging Therapies 68 Stress Incontinence 68 Renal Disease 68 Virus Infection 68 Recurrent Prostate Cancer 68 Cardiovascular Risk Reduction 68 Phase 2a Trial 68 Lower Blood Pressure 68 Cholesterol Lowering Drugs 68 Drug Eluting 68 Renal Failure 68 Asthma Medication 68 Vitamin D Supplementation 68 Lymphoma Patients 68 Cocaine Addiction 68 Post Menopausal 68 Genetic Mutation 68 Contraceptive Use 68 Pneumococcal Disease 68 Lung Transplants 68 Blood Transfusions 68 Bipolar Mania 68 Breast Cancer Cells 68 Thyroid Cancer 68 Clinical Practice Guidelines 68 Arthritis Drugs 68 Allergic Asthma 68 Study Evaluates 68 Lowers Blood Pressure 68 Endovascular Repair 68 Respiratory Problems 68 Abdominal Fat 68 Thrombolytic Therapy 68 Inhaled Insulin 68 Peptic Ulcer 68 Guideline Update 68 Pancreatic Adenocarcinoma 68 Treating Prostate Cancer 68 Hip Replacement Surgery 68 Oral Cavity 68 Respiratory Illness 68 Oral Mucositis 68 Prevent Fractures 68 Complete Remission 68 Lipid Levels 68 First Patient Treated 68 Contrast Agent 68 Oral Calcitonin 68 Inflammatory Disease 68 Catheter Ablation 68 Eye Diseases 68 Schizophrenia Treatment 68 Atypical Antipsychotics 68 Randomized Double Blind Placebo 68 Diabetic Kidney Disease 68 J Am Coll 68 Phase 2b Trial 68 Cervical Cancer Vaccine 68 Transplant Rejection 68 Thrombolysis 68 Aortic Dissection 68 Vitamin D Linked 68 Lipid Lowering 68 Genetic Predisposition 68 Short Stature 68 Acute Otitis Media 68 Childhood Asthma 68 Blood Pressure Lowering 68 Breast Cancer Metastasis 68 Double Blind Randomized 68 Autoimmune Diseases 68 Spinal Manipulation 68 Reduces Pain 68 Genetic Variations 68 Refractory Angina 68 Percutaneous Tibial Nerve Stimulation 68 Liver Transplants 68 Seasonal Influenza Vaccine 68 Decompensated Heart Failure 68 Drug Resistant Bacteria 68 Neoadjuvant 68 Childhood Vaccinations 68 Atypical Hemolytic Uremic Syndrome 68 Psychiatric Illness 68 Prenatal Exposure 68 Vitamin D Levels 68 Survival Rate 68 Epoetin Alfa 68 Therapeutic Efficacy 68 Useful Tool 68 Racial Disparities 68 Ischaemic 68 Protease Inhibitor 68 Contralateral 67 Kidney Tumors 67 Showed Significant 67 Vertebral Compression Fractures 67 Peanut Allergy 67 Improve Patient Outcomes 67 Severely Obese 67 Blood Thinners 67 Genetic Marker 67 Schizophrenia Drug 67 Dyslipidemia 67 Knee Arthritis 67 Ethnic Disparities 67 Novel Antibiotic 67 Calcium Supplements 67 Chronic Lung 67 Hepatitis C Infection 67 Phase IIa Clinical Trial 67 Erectile Dysfunction Drug 67 Acute Myocardial 67 Juvenile Idiopathic Arthritis 67 Clinical Guideline 67 Community Acquired Pneumonia 67 Helps Identify 67 Weight Loss Drug 67 Gene Variants 67 Could Predict 67 IND Filing 67 Radiation Doses 67 Prostate Cancer Diagnosis 67 Morbidity Mortality 67 Bone Marrow Cells 67 Antihypertensive 67 Lumbar Spine 67 Hyperlipidemia 67 Serious Side Effects 67 Refractory Hodgkin Lymphoma 67 Genetic Variants 67 Treatment Approaches 67 Intravenous Formulation 67 Muscle Wasting 67 Genetic Mutations 67 Hyperkalemia 67 REMINDER ORLive Presents 67 Malignancy 67 Help Predict 67 Taxane 67 Brain Aneurysms 67 Significant Improvement 67 Completes Enrollment 67 Drug Fails 67 Alternative Treatments 67 Teva Provides Update 67 Demonstrates Potent 67 Male Contraceptive 67 Observational Studies 67 Advanced Pancreatic Cancer 67 Non Alcoholic Fatty 67 Cigarette Smoke 67 Study Validates 67 Coronary Intervention 67 Life Threatening 67 Non Alcoholic Steatohepatitis 67 Stroke Risk 67 Genital Herpes 67 Study Shows Promise 67 Could Prevent 67 Prostate Screening 67 Psoriasis Patients 67 Acute Migraine 67 Malignant Glioma 67 Guidelines Recommend 67 Adverse Outcomes 67 Causes Symptoms 67 Autoimmune Disorders 67 Cause Mortality 67 Improved Outcomes 67 Pivotal Clinical Trial 67 Cesarean Delivery 67 Placebo Effect 67 Pivotal Trial 67 II Clinical Trial 67 Clinically Significant 67 Rheumatoid Arthritis Drug 67 Premature Births 67 Male Fertility 67 Treatment Naive HIV 67 Neoplasms 67 #:#-#,# CrossRef Medline [002] 67 Dose Ranging Study 67 STRIDE PD 67 Stem Cell Transplant 67 Resection 67 Pain Medications 67 Expanded Indication 67 Chronic HCV 67 Watchful Waiting 67 Circulating Tumor Cells 67 Ovarian Cancer Treatment 67 Abortion Pill 67 MMR Vaccine 67 Certain Cancers 67 Brain Shrinkage 67 Stress Urinary Incontinence 67 Vaginal Gel 67 Antipsychotic 67 Trial Evaluating 67 Abdominal Surgery 67 Resistant Bacteria 67 Helps Relieve 67 Stem Cell Procedure 67 Abdominal Pain 67 Hernia Repair 67 Allogeneic 67 Prostate Cancer Survival 67 Infarct 67 Hemolysis 67 Migraine Sufferers 67 Completes Patient Enrollment 67 Anti Inflammatory Drug 67 NPS Pharmaceuticals Announces 67 Mesothelioma Treatment 67 Embolization 67 ADHD Medication 67 Chronic Myeloid Leukemia 67 Novel Method 67 Liver Cirrhosis 67 Vaccine Candidate 67 Relapsed Refractory 67 Tonsillectomy 67 Tyrosine Kinase Inhibitor 67 Novel Therapeutic 67 Substantially Reduce 67 Pregnancy Complications 67 Secondary Endpoints 67 Bare Metal Stent 67 Risedronate 67 Gastric Ulcers 67 Advanced Gastric Cancer 67 Suicidal Thoughts 67 Maven Semantic 67 Desvenlafaxine Succinate 67 Dose Response 67 Parenteral Nutrition 67 Commonly Prescribed 67 Metabolic Endocrinology 67 Detecting Breast Cancer 67 Valvular 67 Premature Babies 67 Symptom Improvement 67 Phase 2a Clinical Trial 67 Angiographic 67 Patients Enrolled 67 Breast Cancer Treatments 67 Reduced Incidence 67 Metastatic Melanoma 67 Novel Oral 67 Calcium Vitamin D 67 Viral Load 67 Diabetic Neuropathic Pain 67 Antiviral Activity 67 Gout Patients 67 Sudden Cardiac Death 67 Breast Tissue 67 Vascular Disease 67 Inhaled Liposomal Ciprofloxacin 67 Novel Therapies 67 Staph Infections 67 Randomized Evaluation 67 Kidney Donors 67 Nebulized 67 Prospective Randomized Study

Back to home page